Place of Origin : Shaoxing,China
Post Date : 12-05-2020
Expiry Date : 13-06-2025

QUICK OVERVIEW
Product Name Liraglutide;
Cas No. 204656-20-2;
Sequence H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(N-e-(Na-Palmitoyl-L-?-glutamyl))-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH;
Molecular Formula C172H265N43O51;
Molar Mass 3751.202 G/mol;
Purity =98%;
Impurity =0.5% ;
Storage Temperature 2-8?;
Packing Size 1G/Bottle, 10G/Bottle,50G/Bottle Or At Customers Reqirement.

Function: Liraglutide Is For The Treatment Of Diabetes Type 2.

Mechanism Of Actions: Liraglutide Is A Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Indicated To Improve Glycemic Control In Adults With Type 2 Diabetes Mellitus, And To Reduce The Risk Of Heart Attack, Stroke And CV Death In Adults With Type 2 Diabetes And Established CV Disease.
It Was Approved By The FDA On December 23, 2014 And By The European Medicines Agency On January 23, 2015, For Adults With A Body Mass Index (BMI) Of 30 Or Greater (obesity) Or A BMI Of 27 Or Greater (overweight) Who Have At Least One Weight-related Condition.

Originator Company: Novo Nordisk

Dosage For Finished Formulation: 18 Mg/3ml

Similar Effect Peptides: Exenatide, Semaglutide

Generic API Process In Our Company: Liraglutide Is One Of Our Main Peptide Projects, Related Documents Will Be Submitted To The International FDA.